ARBs linked with cancer Radiation-hormone therapy combo best for high-risk prostate cancer Long-term rituximab cuts lymphoma recurrence risk Elderly lung CA patients benefit from aggressive chemo ‘Remarkable’ four-month improvement in survival will change practice, researchers say Selenium a bust in lung cancer Supplement fails to prevent secondary tumour development Sponge-derived drug extends breast CA survival Eribulin among ‘handful’ of effective agents for metastatic disease Targeted lung cancer drug wows meeting Promising early trial results for crizotinib highlighted in plenary session Tool aids ovarian CA screening Many NPs lack oncology expertise: study Supervising physicians act as educators for NPs new to oncology. Yondelis approved for relapsed ovarian cancer First Previous 70 71 72 73 74 Next Last
